Johanna Richter

graph of relations

Publications

  1. 2024
  2. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

    Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C. & Kröger, N., 14.06.2024, In: MED-CAMBRIDGE. 5, 6, p. 550-558.e2

    Research output: SCORING: Contribution to journalCase reportResearchpeer-review

  3. "A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study

    Volz, T., Sippel, A., Fischbach, F., Richter, J., Willison, A. G., Häußler, V. & Heesen, C., 01.05.2024, In: FRONT NEUROL. 15, p. 1384551

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation

    Oechsler, S., Gagelmann, N., Wolschke, C., Janson, D., Badbaran, A., Klyuchnikov, E., Massoud, R., Rathje, K., Richter, J., Schäfersküpper, M., Niederwieser, C., Kunte, A., Heidenreich, S., Ayuk, F. & Kröger, N., 04.2024, In: BONE MARROW TRANSPL. 59, 4, p. 550-557 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life

    Braun, B., Fischbach, F., Richter, J., Pfeffer, L. K., Fay, H., Reinhardt, S., Friese, M. A., Stellmann, J-P., Kröger, N. M., Heesen, C. & Häußler, V., 02.2024, In: MULT SCLER RELAT DIS. 82, p. 105414

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review